PAS
MRK icon

Park Avenue Securities’s Merck MRK Stock Holding History

Park Avenue Securities’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.7M Sell
106,866
-2,109
-2% -$247K 0.09% 187
2026
Q1 		$13.1M Buy
108,975
+26,683
+32% +$3.08M 0.1% 148
2025
Q4 		$8.66M Buy
82,292
+5,303
+7% +$498K 0.07% 216
2025
Q3 		$6.46M Buy
76,989
+18,839
+32% +$1.55M 0.05% 271
2025
Q2 		$4.6M Buy
+58,150
New +$4.62M 0.04% 293
2025
Q1 		– Sell
-94,603
Closed -$9.41M – 1397
2024
Q4 		$9.41M Sell
94,603
-10,264
-10% -$1.06M 0.1% 143
2024
Q3 		$11.9M Sell
104,867
-19,615
-16% -$2.33M 0.13% 108
2024
Q2 		$15.4M Sell
124,482
-2,267
-2% -$292K 0.19% 80
2024
Q1 		$16.7M Sell
126,749
-1,377
-1% -$170K 0.22% 73
2023
Q4 		$14M Sell
128,126
-15,401
-11% -$1.6M 0.19% 72
2023
Q3 		$14.8M Sell
143,527
-193
-0.1% -$20.8K 0.23% 63
2023
Q2 		$16.6M Buy
143,720
+18,427
+15% +$2.09M 0.26% 50
2023
Q1 		$13.3M Sell
125,293
-2,570
-2% -$277K 0.23% 61
2022
Q4 		$14.2M Buy
127,863
+3,589
+3% +$367K 0.25% 58
2022
Q3 		$10.7M Buy
124,274
+7,695
+7% +$687K 0.21% 62
2022
Q2 		$10.6M Buy
116,579
+16,709
+17% +$1.48M 0.21% 60
2022
Q1 		$8.19M Buy
99,870
+4,783
+5% +$377K 0.14% 83
2021
Q4 		$7.29M Buy
95,087
+6,617
+7% +$527K 0.13% 95
2021
Q3 		$6.64M Buy
88,470
+2,257
+3% +$172K 0.13% 84
2021
Q2 		$6.71M Sell
86,213
-1,407
-2% -$105K 0.14% 72
2021
Q1 		$6.45M Buy
87,620
+14,279
+19% +$1.05M 0.16% 58
2020
Q4 		$5.72M Buy
73,341
+7,491
+11% +$573K 0.16% 55
2020
Q3 		$5.21M Buy
65,850
+5,593
+9% +$438K 0.17% 56
2020
Q2 		$4.45M Buy
60,257
+8,225
+16% +$619K 0.17% 56
2020
Q1 		$3.82M Buy
52,032
+6,533
+14% +$513K 0.32% 29
2019
Q4 		$3.95M Buy
45,499
+8,550
+23% +$702K 0.16% 54
2019
Q3 		$2.97M Buy
36,949
+5,099
+16% +$409K 0.14% 59
2019
Q2 		$2.55M Buy
31,850
+4,588
+17% +$351K 0.28% 31
2019
Q1 		$2.17M Buy
27,262
+2,723
+11% +$204K 0.12% 65
2018
Q4 		$1.75M Buy
24,539
+4,118
+20% +$291K 0.27% 28
2018
Q3 		$1.39M Buy
20,421
+1,940
+10% +$124K 0.22% 33
2018
Q2 		$1.07M Sell
18,481
-40
-0.2% -$2.26K 0.19% 36
2018
Q1 		$941K Buy
18,521
+3,464
+23% +$187K 0.21% 34
2017
Q4 		$808K Buy
15,057
+1,928
+15% +$107K 0.21% 32
2017
Q3 		$809K Buy
13,129
+2,076
+19% +$126K 0.25% 25
2017
Q2 		$647K Buy
+11,053
New +$673K 0.07% 68
2017
Q1 		– Sell
-6,604
Closed -$379K – 66
2016
Q4 		$379K Sell
6,604
-200
-3% -$11.7K 0.19% 27
2016
Q3 		$406K Buy
6,804
+1,410
+26% +$82.5K 0.24% 20
2016
Q2 		$298K Buy
+5,394
New +$287K 0.05% 60

Other funds holding MRK

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Park Avenue Securities's MRK Position: Q2 2026 in Review

Park Avenue Securities reduced its Merck (MRK) stake by 1.9% in Q2 2026, selling an estimated $247K and leaving 106,866 shares worth $13.7M. The position accounts for 0.09% of the portfolio, ranked #187.

Park Avenue Securities first reported a position in MRK in Q2 2016 and has held it in 39 quarters since. The position peaked at $16.7M in Q1 2024. 1,533 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Park Avenue Securities held 106,866 shares of Merck worth $13.7M as of Q2 2026.
  • Park Avenue Securities sold 2,109 Merck shares in Q2 2026, an estimated $247K.
  • Merck made up 0.09% of Park Avenue Securities's portfolio in Q2 2026, its #187 holding.
  • Park Avenue Securities first reported a position in Merck in Q2 2016 and has held it in 39 quarters since.
  • Park Avenue Securities's Merck position peaked at $16.7M in Q1 2024.
  • 1,533 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.